Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Funding types
Funding types
Shareholder Investment
Products 121 to 129 of 129
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
SYN-005
by
Synthetic Biologics
+
Intrexon
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/01 09:27 (7 years ago)
Known funding amount:
24,800,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
SYN
(NYSEMKT)
Value chain stage:
Finished Product
SYNB1020
by
Synlogic
Biotech components:
Microbe
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
+
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
125,800,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
SYBX
(NASDAQ)
Value chain stage:
Finished Product
SYNB1618
by
Synlogic
Biotech components:
Microbe
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
+
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/08 14:53 (7 years ago)
Known funding amount:
125,800,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
SYBX
(NASDAQ)
Value chain stage:
Finished Product
TALEN
by
Cellectis
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
+
France
Country of distribution:
USA
+
France
Intended consumer:
Research
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
17,400,000 EUR
Funding types:
Shareholder Investment
Industry:
Health
+
Multipurpose
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Research
Production process:
Closed Production
Source:
Web search
Trading symbol:
CLLS, ALCLS
(NASDAQ, EPA)
Value chain stage:
Platform
UltraClean Diesel
by
Renewable Energy Group
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
244,500,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
REGI
(NASDAQ)
Value chain stage:
Finished Product
Vanillin
by
Evolva
Biotech components:
Microbe
+
Fungus
Business models:
B2B
Country of production:
USA
Country of distribution:
Switzerland
+
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
Xylathin Xylanase (#1)
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2019/05/15 15:44 (6 years ago)
Known funding amount:
2,147,483,647 EUR
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Zemea® 1,3-Propanediol
by
DuPont
+
Tate & Lyle Bio Products
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
+
UK
Country of distribution:
USA
+
Asia Pacific
+
Europe
Intended consumer:
Consumer
+
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
Zemea USP
by
DuPont
+
Tate & Lyle Bio Products
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
+
UK
Country of distribution:
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/09/19 16:00 (7 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Health
+
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
+
Chemical
+
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
1
…
4
5
6
7
8
9
10
11
12
13
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
